Abel de la Rosa
Direktor/Vorstandsmitglied bei VIRIOS THERAPEUTICS, INC.
Profil
Abel de la Rosa is the founder of Antios Therapeutics, Inc. He is currently an Independent Director at Virios Therapeutics, Inc. since 2020.
Previously, he served as a Director at Celtaxsys, Inc. from 2012 to 2020.
Prior to that, he was the VP-Business Development & Scientific Affairs at Pharmasset, Inc. from 2002 to 2012.
Abel also held the position of Chief Scientific Officer at Drug Innovation Ventures At Emory LLC from 2012 to 2018, as well as at Emory Institute For Drug Development from 2012 to 2018.
Dr. de la Rosa obtained a doctorate degree from Miami University and an undergraduate degree from the University of California San Diego.
Aktive Positionen von Abel de la Rosa
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.12.2020 |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Gründer | - |
Ehemalige bekannte Positionen von Abel de la Rosa
| Unternehmen | Position | Ende |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | 01.01.2020 |
| Drug Innovation Ventures At Emory LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Ausbildung von Abel de la Rosa
| University of California San Diego | Undergraduate Degree |
| Miami University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Drug Innovation Ventures At Emory LLC | |
Emory Institute For Drug Development
Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
